| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/27/2002 | EP0892681B1 Two-chamber cartridge for propellant-free metered aerosols |
| 02/27/2002 | EP0889710B1 Improvements in or relating to encapsulation |
| 02/27/2002 | EP0868172B1 Direct compression carbonyl iron tablet |
| 02/27/2002 | EP0859634B1 Pharmaceutical compositions containing platelet aggregation inhibitors |
| 02/27/2002 | EP0836380B1 Fgf9 as a specific ligand for fgfr3 |
| 02/27/2002 | EP0797441B1 Pharmaceutical composition comprising lamotrigine |
| 02/27/2002 | EP0788350B1 Small particle formation |
| 02/27/2002 | EP0784466B1 Use and composition of an anti-sexually transmitted diseases formulation |
| 02/27/2002 | EP0759300B1 process for producing molten granulated sucralfate preparations |
| 02/27/2002 | CN2478613Y External-use drug towel bag |
| 02/27/2002 | CN1337966A Hesperitin pro-forms with enhanced bioavailability |
| 02/27/2002 | CN1337931A Retinoid antagonists and use thereof |
| 02/27/2002 | CN1337884A Gene therapy for cardiomyopathy |
| 02/27/2002 | CN1337882A Pharmaceutical composition for the treatment o f rheumatic syndromes containing sulfur, mustard seeds and a copper salt |
| 02/27/2002 | CN1337878A Methods for treating overian cancer, poly(phosphoester) compositions, and biodegradable articles for same |
| 02/27/2002 | CN1337877A Method of preparing stable suspension of insoluble microparticles |
| 02/27/2002 | CN1337876A Fast dispersing dosage forms free of gelatin |
| 02/27/2002 | CN1337874A A cosmetic composition based on methol and menthyl lactate, having little odor and being non-irritating |
| 02/27/2002 | CN1337261A Wudu ointment |
| 02/27/2002 | CN1337250A Compound Wuduqing capsule of blister beetle |
| 02/27/2002 | CN1337249A Liposoluble Chinese medicine rectal suppository for treating acute and chronic prostatitis |
| 02/27/2002 | CN1337242A Production process of efficient fine herbal medicine pieces |
| 02/27/2002 | CN1337227A Soluble liquide preparation of liposoluble matter |
| 02/27/2002 | CN1337226A Calamine lotion |
| 02/27/2002 | CN1337225A Transdermal physiotherapeutic medicine gel |
| 02/27/2002 | CN1079833C Recombinant P53 adenovirus method and compositions |
| 02/27/2002 | CN1079680C Preservative system for contract lens solutions |
| 02/27/2002 | CN1079678C Long-lasting aqueous dispersions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof |
| 02/27/2002 | CN1079674C Flavanolignan preparation, its processing method and pharmaceutical compositions containing them |
| 02/27/2002 | CN1079672C Oral liquid alendronate formulations |
| 02/27/2002 | CN1079670C Sublingual or buccal pharmaceutical composition |
| 02/27/2002 | CN1079668C Injectable liposumal pharmaceutical preparation |
| 02/27/2002 | CN1079665C Personal cleansing compositions |
| 02/27/2002 | CN1079660C Miniming trichomadesis with anti-fungus compound and halogeno-anti-bacteria compound |
| 02/26/2002 | US6350853 Conjugated peptide nucleic acids having enhanced cellular uptake |
| 02/26/2002 | US6350786 Complexes significantly increase the bioavailability of poorly soluble therapeutically active compounds |
| 02/26/2002 | US6350784 Phytochemicals, surfactant, folic acid, |
| 02/26/2002 | US6350739 Methods of prevention and treatment of ischemic damage |
| 02/26/2002 | US6350594 A method using cultured plant cell gums produced from gum-secreting cells of vascular plants in a variety of food, drugs, veterinary, cosmetics and industry |
| 02/26/2002 | US6350527 Gels and multilayer surface structures from boronic acid containing polymers |
| 02/26/2002 | US6350480 Polymer with softeners, emulsiers, fillers for chewing gum |
| 02/26/2002 | US6350471 Tablet comprising core consisting of selected active ingredient and conventional excipients, and coating consisting of water-insoluble, water-permeable film-forming polymer, water-soluble polymer and plasticizer |
| 02/26/2002 | US6350470 Effervescent drug delivery system for oral administration |
| 02/26/2002 | US6350469 Tablet comprising compacted mixture of methylcellulose having high viscosity and edible calcium salt selected from dibasic calcium phosphate dihydrate, calcium phosphate anhydrous, and tribasic calcium phosphate, or mixtures thereof |
| 02/26/2002 | US6350468 Double capsule for the administration of active principles in multiple therapies |
| 02/26/2002 | US6350467 Pharmaceutical preparations of glutathione and methods of administration thereof |
| 02/26/2002 | US6350464 Methods for treating ovarian cancer, poly (phosphoester) compositions, and biodegradable articles for same |
| 02/26/2002 | US6350462 Porous ceramic body having hollow for retaining medicament and which controls release thereof, which is capsule-shaped and has pores extending inwardly of outer periphery, each of which has diameter proportional to distance from outer periphery |
| 02/26/2002 | US6350458 Mixed micellar drug deliver system and method of preparation |
| 02/26/2002 | US6350442 Ocular treatment using cyclosporin-A derivatives |
| 02/26/2002 | US6350435 Composition for the treatment of halitosis |
| 02/26/2002 | US6350432 Pressurized containers with propellants and glycerin derivatives |
| 02/26/2002 | US6350398 Process for producing coated solid dosage forms |
| 02/26/2002 | CA2284470C New crystalline form of omeprazole |
| 02/26/2002 | CA2237883C Process for the preparation of materials with a high content of long chain polyunsaturated fatty acids |
| 02/26/2002 | CA2048471C Water-containing liposome system |
| 02/26/2002 | CA2025728C Antimicrobial compositions |
| 02/21/2002 | WO2002014876A2 Test unit and method for the production of stable formulations |
| 02/21/2002 | WO2002014448A2 Adhesive blends comprising hydrophilic and hydrophobic pressure sensitive adhesives |
| 02/21/2002 | WO2002014403A2 Acid end group poly(d,l-lactide-co-glycolide) copolymers with high glycolide content |
| 02/21/2002 | WO2002014360A1 Integrin binding motif containing peptides and methods of treating skeletal diseases |
| 02/21/2002 | WO2002014288A1 Use of triazinetrione sulfones for combating coccidiosis |
| 02/21/2002 | WO2002014279A1 New aporphine esters and their use in therapy |
| 02/21/2002 | WO2002014251A1 Method for obtaining cocoa bean polyphenol extracts, resulting extracts and uses thereof |
| 02/21/2002 | WO2002013982A1 Compositions including ammonia oxidizing bacteria to increase production of nitric oxide and nitric oxide precursors and methods of using same |
| 02/21/2002 | WO2002013870A2 Formulation for administering therapeutic lipophilic molecules |
| 02/21/2002 | WO2002013869A2 Flavone-containing plant extract solutions having improved storage and heat stability |
| 02/21/2002 | WO2002013868A1 Dermatological formulation |
| 02/21/2002 | WO2002013858A1 Oral solid dose vaccine |
| 02/21/2002 | WO2002013856A2 W/o emulsion adjuvant compositions for vaccines |
| 02/21/2002 | WO2002013839A1 Animal papilla disinfectants and method of improving microbial environment |
| 02/21/2002 | WO2002013831A1 Use of triazinetrione sulfoxides for controlling coccidioses |
| 02/21/2002 | WO2002013829A1 Compositions containing an inhibitor of dihydrofolate reductase and a folate |
| 02/21/2002 | WO2002013823A1 Micronized torsemide |
| 02/21/2002 | WO2002013822A1 Micronized leflunomide |
| 02/21/2002 | WO2002013819A1 Seamless soft capsule preparations containing dihydrobenzofuran derivatives |
| 02/21/2002 | WO2002013817A1 Remedies for cisplatin-tolerant cancer |
| 02/21/2002 | WO2002013816A1 Pharmaceutical composition |
| 02/21/2002 | WO2002013815A1 Oral drug composition containing a verapamil derivative as a drug-absorption promotor |
| 02/21/2002 | WO2002013810A1 Water-soluble prodrugs of propofol for treatment of migraine |
| 02/21/2002 | WO2002013795A1 Use of aromas and flavours |
| 02/21/2002 | WO2002013794A1 Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent |
| 02/21/2002 | WO2002013793A2 Method of making tablets and tablet compositions produced therefrom |
| 02/21/2002 | WO2002013792A1 Drug-containing solid dispersion having improved solubility |
| 02/21/2002 | WO2002013791A2 Steroid hormones as transfer agents |
| 02/21/2002 | WO2002013790A1 Solid dispersion of ipriflavone for oral administration and its manufacturing methods |
| 02/21/2002 | WO2002013789A1 Pharmaceutical composition containing 1'-[4-[1-(4-fluorophenyl)-1h-indole-3-yl] -1-butyl]-spiro[isobenzofuran-1(3h),4'-piperidine] |
| 02/21/2002 | WO2002013787A1 Composite material and process for increasing bioavailability and activity of a beneficial agent |
| 02/21/2002 | WO2002013786A2 Method of forming microparticles |
| 02/21/2002 | WO2002013785A2 Drug delivery system with burst electrode |
| 02/21/2002 | WO2002013784A2 Drug delivery system with bilayer electrodes |
| 02/21/2002 | WO2002013783A2 Process for preparing polymer-based sustained release compositions |
| 02/21/2002 | WO2002013782A1 Oral delivery of peptide |
| 02/21/2002 | WO2002013781A1 Method for preparation of chewing gum with customer acceptable taste |
| 02/21/2002 | WO2002013762A2 Improved solid pharmaceutical dosage formulation of hydrophobic drugs |
| 02/21/2002 | WO2002013755A1 Method of manufacturing seamless capsule |
| 02/21/2002 | WO2002013701A1 Sutures and coatings made from therapeutic absorbable glass |
| 02/21/2002 | WO2002013671A2 Drug release (delivery system) |
| 02/21/2002 | WO2001089482A3 Method for preparing microparticles having a selected polymer molecular weight |
| 02/21/2002 | WO2001085668A8 Optically active 2-aminotetralin derivatives, the processes for the preparation thereof and the therapeutical use of pharmaceutical compositions containing them |